Gastroschisis
What is gastroschisis?
Gastroschisis is a birth defect of the abdominal wall. With this condition the baby’s intestines stick outside of the body through a hole in the abdomen next to the belly button. Gastroschisis occurs early during pregnancy and the hole can be small or large. At times other organs such as the liver and stomach can also be involved. The exposed intestines ad organs can become irritated, swollen, twisted and shortened. It is estimated that 1 in 2,000 babies are born with gastroschisis each year.How is gastroschisis diagnosed?
Gastroschisis can be diagnosed during pregnancy through blood screening and ultrasound. Early detection can assist in safe delivery and intervention after birth. Gastroschisis is seen at the time of birth.What causes gastroschisis?
The exact cause of gastroschisis is unknown. Though it does not appear to be an inherited condition, having a baby born with gastroschisis does seem to make it more likely that another child will be born with this condition. Research is underway to understand the cause.Are there treatment options for gastroschisis?
Treatment for gastroschisis occurs after birth. Treatment cannot occur during pregnancy. Surgery is done very soon after a child is born with gastroschisis. If the opening is small and the intestines that are exposed are not damaged the repair can be done in one step known as a primary repair. If the opening is large and the exposed intestines are swollen the repair must be done in steps known as staged repair. Other treatments include intravenous feeding, infection prevention and close body temperature monitoring. Even with surgical repair, infants can have problems with feeding, digestion, and nutrient absorption.Where can I find more information about gastroschisis?
Gastroschisis Articles

Rezdiffra (Resmetirom) Shows Sustained Benefits in MASH Cirrhosis Over Two Years
Austin Newman
December 13, 2025
Read More »

Sugar-Coated Deception: Discovery of Aggressive Lymphoma Subtype Opens Door to Personalized Cancer Treatment
Bree Clare
December 12, 2025
Read More »

PopEVE Aims to Fast-Track Rare Disease Diagnoses by Ranking Genetic Variant Severity
Bree Clare
December 12, 2025
Read More »

Mann-type DLBCL: Sugar Signature Reveals High-Risk Lymphoma and New Therapeutic Avenues
Bree Clare
December 12, 2025
Read More »

The FDA Grants Traditional Approval for Daratumumab Regime in Amyloidosis
Rose Duesterwald
December 11, 2025
Read More »

Houston Methodist Researchers Identify T Cells That Attack Transplanted Organs
Rose Duesterwald
December 11, 2025
Read More »

RFK’s Granddaughter, Tatiana Schlossberg, Reveals Diagnosis of Rare Blood Cancer
Austin Newman
December 11, 2025
Read More »

FDA Investigates Death Linked to Takeda’s Adzynma Therapy
Austin Newman
December 10, 2025
Read More »